Short Interest in AXIM Biotechnologies, Inc. (OTCMKTS:AXIM) Decreases By 95.4%

AXIM Biotechnologies, Inc. (OTCMKTS:AXIM) saw a significant decrease in short interest in the month of August. As of August 31st, there was short interest totaling 19,085 shares, a decrease of 95.4% from the August 15th total of 417,214 shares. Based on an average daily volume of 731,294 shares, the days-to-cover ratio is currently 0.0 days.

AXIM Biotechnologies Stock Up 5.3%

OTCMKTS AXIM traded up $0.00 during trading hours on Thursday, hitting $0.00. The company’s stock had a trading volume of 59,178 shares, compared to its average volume of 285,802. AXIM Biotechnologies has a 52 week low of $0.00 and a 52 week high of $0.03.

About AXIM Biotechnologies

AXIM Biotechnologies, Inc is a development-stage biotechnology company focused on the research, development and commercialization of cannabinoid-based technologies. The company’s primary objective is to advance formulations and delivery systems for cannabidiol (CBD) and other cannabinoids, targeting applications in nutraceuticals, skincare and medical devices. Through its proprietary encapsulation and atomization techniques, AXIM aims to enhance the bioavailability and stability of cannabinoid compounds for consumer and clinical use.

The company’s product pipeline includes novel CBD-infused nutraceuticals designed to promote general wellness, as well as specialized formulations for topical and inhalation delivery.